Take a look back at some of the most-viewed, top video series with key experts in neurology and their in-depth discussions, part of NeurologyLive®'s Year in Review.
In 2021, the NeurologyLive® studio team was hard at work, with almost 40 new vidoe series premiering episodes on the site this year. These covered topics from all areas of neurology, bringing groups of key opinion leaders together to share their perspectives and insights on the clinical care of patients and research.
These series include Cure Connections, which include physicians, advocacy leaders, and notably, patients, to offer unique and well-rounded perspectives on a select disease state; Insights and Peers & Perspectives, which provide a more intimate setting by featuring either a single expert or a duo discussing an aspect of care; News Network, which features 1-on-1 expert insights on the latest data presented at medical meetings; and NeurologyLive Peer Exchange™, our flagship video series, which features a panel of experts diving into the care of select diseases, discussing points of contention and offering advice to the community.
Take a look back on some of the most engaging and most watched video series in 2021 by clicking the buttons below:
Hosted by June Halper, MSN, APN-C, MSCN, FAAN, a certified adult nurse practitioner specializing in multiple sclerosis, CEO of the Consortium of Multiple Sclerosis Centers, this series features Brian G. Weinshenker, MD, a consultant and a professor of neurology at the Mayo Clinic in Rochester, Minnesota; Jacinta Behne, MA, the executive director of the Guthy-Jackson Charitable Foundation in Beverly Hills, California; and Doug and Kim, individuals with NMOSD. They offer recommendations for identifying neuromyelitis optica spectrum disorders in the community and using immunosuppressive therapy to help prevent acute attacks.
Including Philippa Cheetham, MD, an attending physician at Mount Sinai, the series features Jessica Ailani, MD, the director of the MedStar Georgetown Headache Center and a vice co-chair of strategic planning and a professor of clinical neurology at the MedStar Georgetown University Hospital; and Jill Dehlin, RN, a certified health education specialist, a patient advocate, and 1 of many people with migraine. The group provides patient and clinician insight regarding the challenges associated with migraine and best approaches to preventing and managing attacks with lifestyle intervention and newer therapies.
Hosted by David Kudrow, MD, the medical director of the California Medical Clinic for Headache, this series features in-depth overviews of the use of novel therapies for the acute and preventative approach to migraine, with Kudrow offering his perspective on these available treatment options for migraine management, and the ins and outs of their in-clinic use. He offered insight into the use of gepants, injectables, and calcitonin gene-related peptide inhibitors.
Hosted by expert neurologist and sleep specialist Chris Winter, MD, the owner and president of Charlottesville Neurology and Sleep Medicine, this series provides practical perspectives on the identification and management of narcolepsy and excessive daytime sleepiness, including the causes, subtypes, and symptoms; the differential diagnosis of these conditions; and therapeutic selection among the numerous new options that have made their way to clinic.
Cohosted by Richard S. Isaacson, MD, now-director of FAU Center for Brain Health in the Schmidt College of Medicine at Florida Atlantic University, and Marc E. Agronin, MD, the senior vice president of Behavioral Health and chief medical officer for the MIND Institute at Miami Jewish Health, the pair describe the journey to the FDA approval of aducanumab for the treatment of Alzheimer disease and what this means for clinicians in this series. As experts in the diagnosis and treatment of Alzheimer disease, they offer insight into the implications on the field, and speak to other promising therapies and diagnostic technologies in development.
Including Crystal Proud, MD, from the Children’s Hospital of the King’s Daughters; Claudia Chiriboga, MD, MPH, from Columbia University Irving Medical Center; Tom Crawford, MD, from Johns Hopkins Medicine; Basil Darras, MD, from Boston Children’s Hospital; and Carolina Tesi Rocha, MD, from Lucile Packard Children’s Hospital at Stanford, the group provides a discussion on the importance of early diagnosis and treatment of spinal muscular atrophy and consider data from recent clinical trials of disease-modifying therapy options.
Covering in-depth topics in the care of advanced Parkinson disease, Adolfo Ramirez-Zamora, MD, an associate professor of neurology and division chief of movement disorders at the Norman Fixel Institute for Neurological Diseases at the University of Florida; Joohi Jimenez-Shahed, MD, associate professor of neurology and medical director of movement disorders neuromodulation and brain circuit therapeutics, at the Icahn School of Medicine at Mount Sinai; Aristide Merola, MD, PhD, associate professor of neurology and director of the Madden Center for Parkinson’s Disease and Related Disorders at the Ohio State University, Wexner Medical Center; and Michael J. Soileau, MD, a movement disorder specialist at Texas Movement Disorders Specialists in Georgetown, and a clinical assistant professor at Texas A&M University and adjunct faculty at the Dell Medical School.
Hosted by Amy Perrin Ross, APN, MSN, CNRN, MSCN, an advanced practice consultant nurse from the Chicago area, the series includes Stephanie Agrella, PhD, APN-BC, from Central Texas Neurology Associates; Christen Kutz, PhD, PA-C, from Colorado Springs Neurological Associates; Patricia Melville, RN, MSN, NP-C, MSCN, from Stony Brook University MS Comprehensive Care Center; and Bryan Walker, MHS, PA-C, from Duke University School of Medicine, Department of Neurology. The group offers recommendations for selecting and sequencing therapies used to treat patients with relapsing multiple sclerosis from an advanced practice provider perspective.